| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5687348 | The Journal of Urology | 2017 | 29 Pages |
Abstract
A protein based assay score derived from diagnostic needle biopsy has strong predictive ability for biochemical relapse after surgery. These results suggest that this assay score can be used at the diagnostic stage to identify patients in whom prostate cancer is potentially more biologically aggressive and active treatment should be considered.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Fred Saad, Mathieu Latour, Jean-Baptiste Lattouf, Hugues Widmer, Kevin C. Zorn, Anne-Marie Mes-Masson, Veronique Ouellet, Genevieve Saad, Amol Prakash, Sibgat Choudhury, Gang Han, Pierre Karakiewicz, Jerome P. Richie,